Male-to-male sexual contact and injection drug
use
10,966
9
8,421
8
3,748
6
140
5
194
17
23,495
8
Heterosexual contact
4,536
4
18,075
16
6,913
12
326
11
72
6
29,973
10
Otherb
2,077
2
1,728
2
632
1
84
3
19
2
4,553
2
Subtotal
123,486
100
110,836
100
59,343
100
3,021
100
1,125
100
298,248
100
Female adult or adolescent
Injection drug use
6,911
41
17,497
36
5,479
35
91
17
133
42
30,158
36
Heterosexual contact
9,293
55
30,254
62
9,986
63
390
73
169
54
50,174
61
Otherb
579
3
1,382
3
402
3
52
10
13
4
2,432
3
Subtotal
16,783
100
49,133
100
15,867
100
533
100
315
100
82,764
100
Child (<13 yrs at diagnosis)
Perinatal
506
89
2,397
98
803
95
18
94
10
100
3,748
96
Otherc
59
11
46
2
38
5
1
6
0
0
145
4
Subtotal
566
100
2,443
100
841
100
19
100
10
100
3,893
100
Totald
140,835
162,412
76,052
3,574
1,450
384,906
Note. These
numbers do not represent reported case counts. Rather, these numbers
are point estimates, which result from adjustments of reported
case counts. The reported case counts are adjusted for reporting
delays and for redistribution of cases in persons initially reported
without an identified risk factor. The estimates do not include
adjustment for incomplete reporting.
a
Includes 583 persons of unknown race or
multiple races.
b
Includes hemophilia, blood transfusion,
perinatal, and risk factor not reported or not identified.
c
Includes hemophilia, blood transfusion,
and risk factor not reported or not identified.
d
Includes 1 person of unknown sex. Because
column totals were calculated independently of the values
for the subpopulations, the values in each column may not
sum to the column total.
